CRC Research Update — July 13, 2026
Today's colorectal cancer research highlights
mrd
A collection of 32 issues
CRC Research Update — June 26, 2026
Today's colorectal cancer research highlights
CRC Research Update — June 18, 2026
Today's colorectal cancer research highlights
CRC Research Update — June 09, 2026
Today's colorectal cancer research highlights
This Week in CRC Research — May 31, 2026
Weekly colorectal cancer research intelligence
Blood test after surgery predicts recurrence in metastatic colorectal cancer
Skip to content
The CRC Digest
▪ SCREENING
Blood test after surgery predicts recurrence in metastatic colorectal cancer — Cancer Treatment Reviews
A systematic review and meta-analysis found that detecting circulating tumor DNA (ctDNA) after surgery for metastatic colorectal cancer strongly predicts which patients will experience recurrence. This molecular residual disease (MRD)
CRC Research Update — May 25, 2026
Today's colorectal cancer research highlights
Practical guidance for integrating ctDNA testing into clinical care
Skip to content
The CRC Digest
Practical guidance for integrating ctDNA testing into clinical care
A narrative review summarizes evidence for ctDNA minimal residual disease testing in gastrointestinal cancers, with strongest data supporting use in resected stage II colon cancer. (Clinical and Translational Oncology)
This content is informational only and
CRC Research Update — May 12, 2026
Today's colorectal cancer research highlights
Circulating Tumor DNA Shows Promise for Predicting Colorectal Cancer Recurrence
Skip to content
The CRC Digest
Circulating Tumor DNA Shows Promise for Predicting Colorectal Cancer Recurrence
A review of current evidence suggests circulating tumor DNA has significant prognostic and predictive potential for detecting minimal residual disease and individualizing adjuvant therapy in colorectal cancer. (Klinická Onkologie)
This content is informational only